A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B

.

Source: Human Vaccines and Immunotherapeutics - December 11, 2019 Category: Allergy & Immunology Authors: Allan Ma Bruce Motyka Klaus Gutfreund Yuenian Eric Shi Rajan George Source Type: research